Revenue: The sum of all revenue fields included for a company's operating activities.
Candel Therapeutics, Inc. (CADL) Revenue data is not available for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-21.87M |
|
-- |
|
-- |
|
$22.98M |
|
$-22.98M |
|
$1.11M |
|
$-21.87M |
|
$-21.87M |
|
$-21.87M |
|
$-21.87M |
|
$-21.87M |
|
$-21.87M |
|
$-22.98M |
|
$-22.81M |
|
77.39M |
|
77.39M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$207.35M |
|
$1.90M |
|
$3.76M |
|
$211.11M |
|
$27.39M |
|
$48.20M |
|
$52.13M |
|
$79.52M |
|
$131.59M |
|
$131.59M |
|
$131.59M |
|
78.45M |
|
| Cash Flow Statement Financials | |
$-58.34M |
|
$-0.89M |
|
$142.61M |
|
$120.15M |
|
$203.53M |
|
$83.39M |
|
$6.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.57 |
|
-- |
|
-- |
|
0.27 |
|
0.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-59.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.62% |
|
-16.62% |
|
-10.36% |
|
-12.17% |
|
$1.68 |
|
$-0.77 |
|
$-0.75 |
|